Jocely Lucena Dutra

Jocely Lucena Dutra

Auto-generated profile, based on publicly available information

Jocely Lucena Dutra

Departament of Chemistry, Federal University of São Carlos (UFSCar), São Carlos, Brazil

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 September 2021 in Dalton Transactions
Verified
Journal Article
Closed access
PDF file
KAKamilla M. Alves
Kamilla M. Alves
JAJOAO HONORATO DE ARAUJO-NETO
JOAO HONORATO DE ARAUJO-NETO
LLLuciano Lião
Luciano Lião
VVVivianne S. Velozo-Sa
Vivianne S. Velozo-Sa
AGAdriana P. M. Guedes
Adriana P. M. Guedes
PGPablo Jose Goncalves
Pablo Jose Goncalves
New palladium/diphosphine/pyridylporphyrin complexes, of general formula {TPyP[PdCl(P–P)]4}(PF6)4, interact weakly with DNA and exhibit cytotoxicity against breast cancer cells.

14 June 2024 in Dalton Transactions
Verified
Journal Article
Closed access
PDF file
JDJocely L. Dutra
Jocely L. Dutra
JAJOAO HONORATO DE ARAUJO-NETO
JOAO HONORATO DE ARAUJO-NETO
AGAngélica Graminha
Angélica Graminha
CMCarlos André F. Moraes
Carlos André F. Moraes
KOKleber De Oliveira
Kleber De Oliveira
ABAlzir Azevedo Batista
Alzir Azevedo Batista
Palladium(ii) complexes have stimulated research interest mainly due to their in vitro cytotoxicity against various cancer cell lines and their low cytotoxicity in healthy cells.

25 June 2025 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
MLMauro A. Lima
Mauro A. Lima
Tamara TeixeiraTamara Teixeira
Tamara Teixeira
DFDario Batista Fortaleza
Dario Batista Fortaleza
GPGeorge B. S. Pereira
George B. S. Pereira
AAAmos Olalekan Akinyemi
Amos Olalekan Akinyemi
FRFillipe V. Rocha
Fillipe V. Rocha
Background/Objectives: Cancer remains a major global health challenge, driving the search for novel chemotherapeutic agents. This study aimed to evaluate the structural and biological properties of a series of Pd(II) complexes containing triphenylphosphine and thiosemicarbazone ligands, in order to assess their potential as anticancer agents. Methods: Six Pd(II) complexes with the general formula [PdCl(PPh3)(TSC)] were synthesized and fully characterized by NMR (1H, 1³C, ³1P), FTIR, mass spectrometry, and X-ray diffraction. Their cytotoxic effects were investigated through in vitro assays using 2D and 3D cancer cell models, including clonogenic, wound healing, cell cycle, and apoptosis assays via flow cytometry. Results: Complexes from the B family demonstrated significantly higher cytotoxicity than those from the C family, particularly against ovarian (IC50 < 1 µM) and breast (IC50~2 µM) cancer cell lines. These compounds exhibited superior potency and selectivity compared to cisplatin, with high selectivity indices toward non-tumor cells. Mechanistic studies revealed both cytotoxic and cytostatic effects depending on structural variations, with apoptosis identified as the primary mechanism of cell death. PdB1, in particular, induced a marked increase in late apoptotic populations and maintained its cytotoxic activity in 3D spheroid models by promoting disintegration, loss of cell adhesion, and nuclear fragmentation. Conclusions: The findings underscore the therapeutic promise of Pd(II) complexes, especially PdB1, as potent and selective antineoplastic agents capable of acting effectively in complex tumor environments and potentially overcoming chemoresistance.

13 April 2025 in Research on Chemical Intermediates
Verified
Journal Article
Closed access
PDF file
ESEverton Martins da Silva
Everton Martins da Silva
MPMaria Aparecida Viana Pinheiro
Maria Aparecida Viana Pinheiro
MAMárcio Laranjeira Anselmo
Márcio Laranjeira Anselmo
JDJocely de Lucena Dutra
Jocely de Lucena Dutra
JHJean Araujo Hauradou
Jean Araujo Hauradou
PMPaulo José Sousa Maia
Paulo José Sousa Maia

28 April 2026 in JBIC Journal of Biological Inorganic Chemistry
Verified
Journal Article
Open access
PDF file
JDJocely Lucena Dutra
Jocely Lucena Dutra
JAJoão Honorato de Araujo-Neto
João Honorato de Araujo-Neto
RSRafael Wendel Rodrigues Santana
Rafael Wendel Rodrigues Santana
RGRone Aparecido De Grandis
Rone Aparecido De Grandis
GPGiulia Polinário
Giulia Polinário
ABAlzir Azevedo Batista
Alzir Azevedo Batista
Cancer and tuberculosis remain among the leading causes of morbidity and mortality worldwide, and the emergence of drug resistance in both diseases highlights the urgent need for new therapeutic strategies. In this context, metal-based compounds combined with bioactive natural products have emerged as promising alternatives to conventional drugs. In the present study, a series of silver (I) complexes containing natural products (curcumin, lawsone, lapachol or alizarin) and triphenylphosphine (PPh3) (complexes 1–4) were synthesized and structurally characterized by IR spectroscopy, elemental analysis, molar conductivity, NMR (1H, 13C, 31P{1H}) spectroscopy and single crystal X-ray diffraction. The results of single crystal diffraction show that the two silver complexes are four-coordinated with two PPh3 and two O atoms of natural product, forming a distorted tetrahedral geometry. The in vitro cytotoxicity of silver(I) complexes was evaluated by MTT assay against four cancer cells and two normal cells, the result shows that the complexes presented a low IC50 value in general, including in normal cell lines. The complexes show better cytotoxic activity for A2780cis (cisplatin-resistant ovarian tumor cell line), being nearly 30 times higher than cisplatin. Silver complexes were tested against Mycobacterium tuberculosis (Mtb) reaching the threshold for effective antimicrobial activity. Furthermore, complex 4 showed good activity against clinical isolates of Mtb resistant to multiple first-line anti-TB drugs.

14 April 2026 in RSC Advances
Verified
Journal Article
Open access
PDF file
JDJocely L. Dutra
Jocely L. Dutra
PMPedro H. S. Marcon
Pedro H. S. Marcon
GMGustavo Moselli
Gustavo Moselli
FNFabiano M. Niquini
Fabiano M. Niquini
JCJoão Victor F. da Costa
João Victor F. da Costa
JAJOAO HONORATO DE ARAUJO-NETO
JOAO HONORATO DE ARAUJO-NETO
This work describes the synthesis of six new ruthenium(II) complexes bearing para-substituted benzoic acids of general formula [Ru(L)(dppb)(bipy)]PF6, where L = terephthalic acid (L-CO2H), 4-(chloromethyl)benzoic acid (L-CCl), 4-(bromomethyl)benzoic acid (L-CBr), 4-(amino)benzoic acid (L-NH2), and 4-(nitro)benzoic acid (L-NO2), bipy = 2,2′-bipyridine and dppb = 1,4-bis(diphenylphosphino)butane. The complexes were characterized by elemental analysis, molar conductivity, NMR, cyclic voltammetry, IR spectroscopy and, for selected compounds, single-crystal X-ray diffraction. The binuclear complex RuBi exhibited a differentiated structural and spectroscopic pattern, including solvent-dependent 31P NMR signal duplication associated with the coexistence of closely related conformers, as supported by DFT calculations. Electrochemical investigations revealed Ru2+/Ru3+ redox couples whose E1/2 values strongly depend on the electronic nature of the para substituent, following the trend NO2 > COOH > CH2Br ≈ CH2Cl > NH2. The strongly electron-donating –NH2 group significantly lowers the oxidation potential and introduces an additional ligand-centered oxidation process, highlighting the pronounced electronic modulation imposed by this substituent. The in vitro cytotoxicity of the complexes, free ligands, and cisplatin was evaluated against MDA-MB-231 (breast), A549 (lung), A2780 (ovarian), A2780cis (cisplatin-resistant ovarian), and MRC-5 (non-tumor lung) cell lines using the MTT assay. All ruthenium complexes were more cytotoxic than the corresponding free ligands and cisplatin. Among them, [Ru(L-NH2)(dppb)(bipy)]PF6 (RuNH2) stood out, exhibiting a submicromolar IC50 value (0.5 ± 0.1 µM) against A2780 cells and the highest selectivity index (3.6) of the series. Its superior performance can be correlated with the strong donor character of the –NH2 group, which modulates the redox properties of the metal center and enhances hydrogen-bonding capability, potentially favoring stronger biological interactions. RuNH2 was further investigated in advanced biological assays, showing pronounced morphological alterations, significant reduction in clonogenic survival of A2780 cells, and concentration-dependent accumulation in the sub-G1 phase, consistent with induction of cell death. Finally, all complexes, except RuNH2 due to its intrinsic fluorescence, were evaluated for interaction with human serum albumin, revealing moderate binding affinities compatible with bloodstream transport. Collectively, these findings demonstrate how subtle electronic effects govern redox behavior and cytotoxic performance, highlighting RuNH2 as a promising candidate for ovarian cancer therapy.